Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Agilent Technologies, Inc. Stock Price: Quote, Financials, Forecast & News (A)

Markets open

Agilent Technologies, Inc.

A · NYSE

Overview Financials Earnings Holders Historical Data Analysis

$140.39+$1.190.85%

As of: Aug 5, 2:38 PM

Prev Close: $139.20
Market Cap: $39.65B
Open: —
Trailing P/E: —
Day Range: $141.07 - $138.55
52W Range: $160.27 - $108.35
Forward P/E: —
EPS: —
Volume: 127.66K
Dividend Yield: —
Beta: —
Avg Volume: 1.39M

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Zacks · 6h ago

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

Zacks · 1d ago

Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?

Zacks · 2d ago

Solventum to Report Q2 Earnings: What's in Store for the Stock?

Zacks · 2d ago

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

Zacks · 2d ago How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends

Zacks · 5d ago Stryker (SYK) Q2 Earnings and Revenues Beat Estimates

Zacks · 6d ago Revvity to Report Q2 Earnings: What's in Store for the Stock?

Zacks · 6d ago

Symbol: A
Type: Stock
Sector: Industrials
Industry: Biotechnology: Laboratory Analytical Instruments
Country: North America
Exchange: NYSE

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com.

Analyst Consensus

Buy

17 analysts

$140

Current

—

Low

$155

Average

—

High

Average target implies +10.41% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA · NYSE

$34.791.05%

Revolution Medicines, Inc.RVMD · Nasdaq$194.650.62%

IDEXX Laboratories, Inc.IDXX · Nasdaq$592.760.79%

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share ofTAK · NYSE$16.670.63%